222 related articles for article (PubMed ID: 22640830)
1. All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/β-catenin pathway.
Lim YC; Kang HJ; Kim YS; Choi EC
Eur J Cancer; 2012 Nov; 48(17):3310-8. PubMed ID: 22640830
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway.
Lee SH; Nam HJ; Kang HJ; Kwon HW; Lim YC
Eur J Cancer; 2013 Oct; 49(15):3210-8. PubMed ID: 23876835
[TBL] [Abstract][Full Text] [Related]
3. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
[TBL] [Abstract][Full Text] [Related]
4. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
[TBL] [Abstract][Full Text] [Related]
5. Cellular characteristics of head and neck cancer stem cells in type IV collagen-coated adherent cultures.
Lim YC; Oh SY; Kim H
Exp Cell Res; 2012 Jun; 318(10):1104-11. PubMed ID: 22426199
[TBL] [Abstract][Full Text] [Related]
6. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A
Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877
[TBL] [Abstract][Full Text] [Related]
7. CD44-negative cells in head and neck squamous carcinoma also have stem-cell like traits.
Oh SY; Kang HJ; Kim YS; Kim H; Lim YC
Eur J Cancer; 2013 Jan; 49(1):272-80. PubMed ID: 22770891
[TBL] [Abstract][Full Text] [Related]
8. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
Miyano K; Cabral H; Miura Y; Matsumoto Y; Mochida Y; Kinoh H; Iwata C; Nagano O; Saya H; Nishiyama N; Kataoka K; Yamasoba T
J Control Release; 2017 Sep; 261():275-286. PubMed ID: 28666729
[TBL] [Abstract][Full Text] [Related]
9. [All-trans retinoic acid effectively inhibits breast cancer stem cells growth in vitro].
Zeng WG; Hu P; Wang JN; Liu RB
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):89-93. PubMed ID: 23714660
[TBL] [Abstract][Full Text] [Related]
10. The effect of targeted therapy on recruited cancer stem cells in a head and neck carcinoma model.
Marcu LG; Marcu D
Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28857306
[TBL] [Abstract][Full Text] [Related]
11. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
[TBL] [Abstract][Full Text] [Related]
12. All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth.
Nguyen PH; Giraud J; Staedel C; Chambonnier L; Dubus P; Chevret E; Bœuf H; Gauthereau X; Rousseau B; Fevre M; Soubeyran I; Belleannée G; Evrard S; Collet D; Mégraud F; Varon C
Oncogene; 2016 Oct; 35(43):5619-5628. PubMed ID: 27157616
[TBL] [Abstract][Full Text] [Related]
13. Receptor for advanced glycation end product blockade enhances the chemotherapeutic effect of cisplatin in tongue squamous cell carcinoma by reducing autophagy and modulating the Wnt pathway.
Zhao Z; Wang H; Zhang L; Mei X; Hu J; Huang K
Anticancer Drugs; 2017 Feb; 28(2):187-196. PubMed ID: 27831944
[TBL] [Abstract][Full Text] [Related]
14. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M
Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261
[TBL] [Abstract][Full Text] [Related]
15. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
Lim YC; Kang HJ; Moon JH
Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids.
Wan H; Oridate N; Lotan D; Hong WK; Lotan R
Cancer Res; 1999 Jul; 59(14):3518-26. PubMed ID: 10416619
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of CD44 sensitizes cisplatin-resistance and affects Wnt/β-catenin signaling in HNSCC cells.
Roy S; Kar M; Roy S; Padhi S; Kumar A; Thakur S; Akhter Y; Gatto G; Banerjee B
Int J Biol Macromol; 2020 Apr; 149():501-512. PubMed ID: 31953176
[TBL] [Abstract][Full Text] [Related]
18. RXRα-enriched cancer stem cell-like properties triggered by CDDP in head and neck squamous cell carcinoma (HNSCC).
Jiang P; Xu C; Zhou M; Zhou H; Dong W; Wu X; Chen A; Feng Q
Carcinogenesis; 2018 Feb; 39(2):252-262. PubMed ID: 29228308
[TBL] [Abstract][Full Text] [Related]
19. All-trans retinoic acid modulates bone morphogenic protein 9-induced osteogenesis and adipogenesis of preadipocytes through BMP/Smad and Wnt/β-catenin signaling pathways.
Liu Y; Liu Y; Zhang R; Wang X; Huang F; Yan Z; Nie M; Huang J; Wang Y; Wang Y; Chen L; Yin L; He B; Deng Z
Int J Biochem Cell Biol; 2014 Feb; 47():47-56. PubMed ID: 24300824
[TBL] [Abstract][Full Text] [Related]
20. Interplay between EZH2/β-catenin in stemness of cisplatin-resistant HNSCC and their role as therapeutic targets.
Milan TM; Eskenazi APE; Oliveira LD; Silva GD; Bighetti-Trevisan RL; Freitas GP; Almeida LO
Cell Signal; 2023 Sep; 109():110773. PubMed ID: 37331417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
